{"href":"https://api.simplecast.com/oembed?url=https%3A%2F%2Foncologypodcast.simplecast.com%2Fepisodes%2Fned-talk-avoiding-btki-aes-part-1-GZrhdiDo","width":444,"version":"1.0","type":"rich","title":"Strategies for Avoiding Adverse Reactions to BTK Inhibitor Therapy, Part 1: Drug–Drug and Drug–Food Interactions","thumbnail_width":300,"thumbnail_url":"https://image.simplecastcdn.com/images/165defb8-f7d7-44fe-a7eb-a59f2c35d334/ad0fb949-6cac-49fb-a7d0-73df8ff2cc93/btki-ae-and-adherence-wc-podcasticon-avoiding-1.jpg","thumbnail_height":300,"provider_url":"https://simplecast.com","provider_name":"Simplecast","html":"<iframe src=\"https://player.simplecast.com/962263a6-0d35-445b-8d18-cb721117c173\" height=\"200\" width=\"100%\" title=\"Strategies for Avoiding Adverse Reactions to BTK Inhibitor Therapy, Part 1: Drug–Drug and Drug–Food Interactions\" frameborder=\"0\" scrolling=\"no\"></iframe>","height":200,"description":"Listen to Sandra E. Kurtin, PhD, ANP-C, AOCN, discuss managing drug–drug and drug–food interactions to minimize adverse events in patients receiving BTK inhibitors."}